ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

CMPS vs RARE // FORWARD P/E MULTIPLE

COMPASS Pathways Plc American Depository Shares (NASDAQ) VS. Ultragenyx Pharmaceutical Inc. (NASDAQ) • 15-METRIC TALLY: CMPS 1 — RARE 2
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CMPS VS. RARE) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC CMPS RARE SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield -9.31% — — TIE /fcf-yield <GO>
Operating Margin — -60.00% — TIE /operating-margins <GO>
Net Profit Margin — -60.00% — TIE /net-margins <GO>
Revenue Growth (YoY) — 20.20% — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — 0.20 — TIE /balance-sheet <GO>
Piotroski F-Score Quality 1/9 3/9 -2.00 RARE /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 51.5 54.9 -3.40 RARE /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple ACTIVE — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $1.69B $1.65B $33.7M CMPS /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR CMPS REV RARE REV CMPS GROSS % RARE GROSS % CMPS FCF RARE FCF
FY 2025 $0 $673.0M — — -$157.2M -$472.0M
FY 2024 $0 $560.0M — — -$119.2M -$421.0M
FY 2023 $0 $434.0M — — -$97.4M -$475.0M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CMPS // BETA —
RARE // BETA —